Touchstone International Medical Science Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042J3
CNY
49.43
-0.97 (-1.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
89.57
65.29
69.58
68.39
72.05
59.64
70.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
89.57
65.29
69.58
68.39
72.05
59.64
70.75
Raw Material Cost
32.19
29.17
30.27
30.44
32.29
26.52
34.53
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.10
0.04
0.00
1.35
0.04
0.02
0.02
Selling and Distribution Expenses
19.58
18.69
20.53
17.90
16.49
15.24
20.63
Other Expenses
0.95
0.82
1.08
0.74
0.80
0.67
1.02
Total Expenditure (Excl Depreciation)
61.35
56.08
61.60
57.04
56.83
48.44
65.40
Operating Profit (PBDIT) excl Other Income
28.2
9.200000000000001
8
11.299999999999999
15.2
11.200000000000001
5.4
Other Income
10.01
4.48
3.53
5.72
1.43
2.06
5.28
Operating Profit (PBDIT)
41.12
16.44
14.20
19.81
19.11
15.68
13.06
Interest
0.10
0.04
0.00
1.35
0.04
0.02
0.02
Exceptional Items
0.55
1.12
-2.81
-0.65
2.32
-0.75
1.19
Gross Profit (PBDT)
57.37
36.11
39.31
37.95
39.76
33.11
36.22
Depreciation
2.96
2.96
2.78
2.78
2.55
2.55
2.23
Profit Before Tax
38.61
14.56
8.61
15.02
18.84
12.36
12.01
Tax
3.59
1.37
-0.53
1.11
1.35
1.01
-2.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
35.02
13.19
9.14
13.90
17.50
11.35
14.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
35.02
13.19
9.14
13.90
17.50
11.35
14.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.02
13.19
9.14
13.90
17.50
11.35
14.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
574.39
571.65
581.43
571.92
599.93
552.69
571.52
Earnings per share (EPS)
0.43
0.16
0.11
0.18
0.22
0.14
0.18
Diluted Earnings per share
0.43
0.16
0.11
0.18
0.22
0.14
0.18
Operating Profit Margin (Excl OI)
31.42%
13.78%
11.34%
16.53%
21.0%
18.57%
7.85%
Gross Profit Margin
46.41%
26.83%
16.38%
26.03%
29.69%
25.0%
20.12%
PAT Margin
39.1%
20.2%
13.14%
20.33%
24.29%
19.04%
20.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 24.27% vs 7.29% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 100.00% vs 17.45% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 75.71% vs 22.92% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Touchstone International Medical Science Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
89.57
0
89.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
89.57
0
89.57
Raw Material Cost
32.19
0
32.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.10
0
0.10
Selling and Distribution Expenses
19.58
0
19.58
Other Expenses
0.95
0.00
0.95
Total Expenditure (Excl Depreciation)
61.35
0
61.35
Operating Profit (PBDIT) excl Other Income
28.22
0.00
28.22
Other Income
10.01
0
10.01
Operating Profit (PBDIT)
41.12
0
41.12
Interest
0.10
0
0.10
Exceptional Items
0.55
0
0.55
Gross Profit (PBDT)
57.37
0
57.37
Depreciation
2.96
0
2.96
Profit Before Tax
38.61
0
38.61
Tax
3.59
0
3.59
Provisions and contingencies
0
0
0.00
Profit After Tax
35.02
0
35.02
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
35.02
0
35.02
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.02
0
35.02
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
574.39
0
574.39
Earnings per share (EPS)
0.43
0
0.43
Diluted Earnings per share
0.43
0
0.43
Operating Profit Margin (Excl OI)
31.42%
0%
0.00
31.42%
Gross Profit Margin
46.41%
0%
0.00
46.41%
PAT Margin
39.10%
0%
0.00
39.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 8.96 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 37.21% vs -6.18% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 24.27% vs 7.29% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 165.15% vs 45.05% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 100.00% vs 17.45% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 159.17% vs 12.15% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 75.71% vs 22.92% in Jun 2024

Quarterly - Interest
Interest 0.01 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.42%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024